Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Net Asset Value Estimate/ Progress on Realisations

25 Jan 2017 07:00

RNS Number : 0186V
LMS Capital PLC
25 January 2017
 

25 January 2017

 

LMS Capital plc

 

Net Asset Value Estimate and Progress on Realisations

 

 

LMS Capital plc (the "Company") is a listed Investment Company focused on investing directly, and through third party funds, in small to medium size private companies in the UK, Europe and the US. Gresham House Asset Management Ltd ("GHAM") was appointed to manage the investment portfolio in August 2016, alongside a change of mandate from realisation to focused direct private equity investment at the smaller end of the market.

 

Since assuming the investment mandate, significant progress has been made in transitioning to external management and towards achieving target annualised cost savings. GHAM has progressively engaged with the underlying portfolio companies, implementing new investment processes under the guidance of its newly established Investment Committee, with a focus on long term shareholder value creation. GHAM has appointed Tim Farazmand to the Investment Committee. Tim has over 30 years' experience in UK mid-market private equity most recently as Managing Director of Lloyds Development Capital and was also Chairman of the British Venture Capital Association.

 

Net Asset Value Estimate

 

The Company has commenced the year end valuation review process which is based on the latest performance updates from portfolio companies and third party fund manager valuations. Whilst valuations of the Company's US investments have benefitted from currency movements, performance in some of the Company's investments has deteriorated since June 2016, impacting their respective valuations.

 

As a consequence, the Board currently estimates that the year-end net asset value will be in the region of £67 million (69.5p per share). This estimate is subject to further evaluation and completion of the annual audit. The estimate takes into account the tender offer in September 2016 which returned £6 million to shareholders and incorporates one off costs associated with the transition from being self-managed to an externally managed company. Once complete, this transition is expected to deliver estimated annualised savings of approximately £1 million.

 

The valuation methodology and policy adopted is consistent with prior years and is in line with IPEV guidelines and takes account of active sales processes where relevant.

 

Progress on Realisations

 

The Company has concluded an agreement to a two stage sale of one of its US investments. The exit valuation is in line with the NAV as of 30 June 2016. The stage 1 payment of $4.5 million was received on 23 January 2017. The second and final stage will be settled either as a one off payment of $5 million in January 2018 or a loan note repayable with interest in instalments over 4 years.

 

The Company has also agreed the realisation of its holding in a US listed companies fund. The realisation is expected to complete in stages during the first half of 2017. The first stage, representing 35% of the holding, has been completed at a premium to 30 June 2016 NAV and proceeds of $1.3 million have been received. The balance is due to be paid in the second quarter of 2017 and will be determined by the NAV of the fund at the time.

 

Realisations since the circular sent to shareholders on 27 July 2016 have totalled £6.9 million. As set out in the circular, when net realisation proceeds reach £12 million, up to £6 million will be returned to shareholders in a tender offer.

 

The company expects to announce its audited results in mid-March.

 

 

Enquiries:

 

LMS Capital PLC

Martin Knight, Chairman

 

0207 935 3555

 

Gresham House Asset Management

Graham Bird, Investment Director

 

0203 837 6275

 

J.P. Morgan Cazenove

Michael Wentworth-Stanley

 

0207 742 4000

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVZLFLDFFZBBE
Date   Source Headline
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:36 pmRNSPrice Monitoring Extension
2nd Feb 20217:00 amRNSNAV and Portfolio Update
7th Jan 20211:59 pmRNSPortfolio Update
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
28th Oct 20207:00 amRNSNet Asset Value(s) 3rd Quarter 2020 update
12th Aug 20207:00 amRNSPortfolio Update
4th Aug 20209:59 amRNSHalf-year Report
25th Jun 20207:13 amRNSResults of 2020 Annual General Meeting
28th May 20201:01 pmRNSAccounts and Notice of AGM
26th May 20207:00 amRNSDISCLOSURE OF RIGHTS ATTACHED TO LISTED SECURITIES
13th May 20204:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.